Serum Leucine-Rich α2 Glycoprotein: A Novel Biomarker for Transmural Inflammation in Crohn's Disease.
Kento TakenakaYoshio KitazumeAmi KawamotoToshimitsu FujiiYumi UdagawaRyosuke WanatabeHiromichi ShimizuShuji HibiyaMasakazu NagahoriKazuo OhtsukaHiroyuki SatoAkihiro HirakawaMamoru WatanabeRyuichi OkamotoPublished in: The American journal of gastroenterology (2022)
LRG is a highly accurate serum biomarker for detecting transmural activity in patients with CD. Results need to be validated in further multicenter studies.